1. Home
  2. HUMA vs TVA Comparison

HUMA vs TVA Comparison

Compare HUMA & TVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • TVA
  • Stock Information
  • Founded
  • HUMA 2004
  • TVA 2024
  • Country
  • HUMA United States
  • TVA United States
  • Employees
  • HUMA N/A
  • TVA N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • TVA
  • Sector
  • HUMA Health Care
  • TVA
  • Exchange
  • HUMA Nasdaq
  • TVA Nasdaq
  • Market Cap
  • HUMA 356.8M
  • TVA 303.4M
  • IPO Year
  • HUMA N/A
  • TVA 2025
  • Fundamental
  • Price
  • HUMA $2.48
  • TVA $10.11
  • Analyst Decision
  • HUMA Strong Buy
  • TVA
  • Analyst Count
  • HUMA 7
  • TVA 0
  • Target Price
  • HUMA $13.00
  • TVA N/A
  • AVG Volume (30 Days)
  • HUMA 4.3M
  • TVA 128.0
  • Earning Date
  • HUMA 08-11-2025
  • TVA 01-01-0001
  • Dividend Yield
  • HUMA N/A
  • TVA N/A
  • EPS Growth
  • HUMA N/A
  • TVA N/A
  • EPS
  • HUMA N/A
  • TVA N/A
  • Revenue
  • HUMA $517,000.00
  • TVA N/A
  • Revenue This Year
  • HUMA N/A
  • TVA N/A
  • Revenue Next Year
  • HUMA $936.09
  • TVA N/A
  • P/E Ratio
  • HUMA N/A
  • TVA N/A
  • Revenue Growth
  • HUMA N/A
  • TVA N/A
  • 52 Week Low
  • HUMA $1.15
  • TVA $9.99
  • 52 Week High
  • HUMA $8.24
  • TVA $10.34
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 53.95
  • TVA N/A
  • Support Level
  • HUMA $2.14
  • TVA N/A
  • Resistance Level
  • HUMA $2.39
  • TVA N/A
  • Average True Range (ATR)
  • HUMA 0.21
  • TVA 0.00
  • MACD
  • HUMA -0.01
  • TVA 0.00
  • Stochastic Oscillator
  • HUMA 48.57
  • TVA 0.00

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share

Texas Ventures Acquisition III Corp is a blank check company.

Share on Social Networks: